Skip to content
Canine PeptideResearch peptides

IGF-1 LR3 dosage for a medium breed

22–77 lb (10–35 kg)

The short answer

For a dog weighing 22–77 lb (10–35 kg), the dose of IGF-1 LR3 reported in the literature is 20-140 mcg per day, given once daily, over 4-6 weeks, then 4 weeks off. It is studied in this weight class primarily for muscle wasting, sarcopenia, post-surgical recovery. These figures are reported as published and are not recommendations — the dose for an individual dog must be set by a veterinarian who has examined the animal.

Worked examples at specific weights

Calculated from the reported range of 1–4 mcg per kg of body weight.

Body weightCalculated dose rangeFrequency
15 kg (33 lb)15–60 mcgOnce daily
23 kg (51 lb)23–92 mcgOnce daily
30 kg (66 lb)30–120 mcgOnce daily

For an exact figure at your dog's weight, use the dose calculator.

Typical breeds in this weight class

Beagle, Border Collie, Australian Shepherd, Bulldog, Cocker Spaniel and similarly sized dogs generally fall within 22–77 lb (10–35 kg). Weigh your dog rather than estimating — dosing is calculated per kilogram and an estimate that is out by a few kilos changes the figure materially, particularly at the smaller end.

Before dosing at all

Contraindicated with active cancer

IGF-1 signalling directly drives cell proliferation. In a dog with an existing malignancy that is precisely the wrong signal. Screening before use is mandatory, not advisory.

Hypoglycaemia risk

IGF-1 LR3 has insulin-like activity and can lower blood glucose. Tremors, disorientation, weakness, or collapse are emergencies. Blood glucose must be monitored, and diabetic dogs require direct veterinary management.

Common questions

How much IGF-1 LR3 for a medium breed?+

For a dog in the 22–77 lb (10–35 kg) range, the reported dose is 20-140 mcg per day, given once daily, typically for 4-6 weeks, then 4 weeks off. At a representative weight of 23 kg (about 51 lb), that works out to roughly 23–92 mcg per dose. These figures are reported from the source literature and are not recommendations.

How often should a medium breed be given IGF-1 LR3?+

Once daily is the reported frequency, over a course of 4-6 weeks, then 4 weeks off. See the cycling guide for how breaks are structured.

Is IGF-1 LR3 safe for a medium breed?+

IGF-1 LR3 demands more caution than anything else on this site apart from the investigational oncology compounds. Two risks are concrete rather than theoretical: it can lower blood glucose enough to cause tremors or collapse, and because IGF-1 signalling drives cell proliferation it is contraindicated in any dog with known or suspected cancer. The mandatory four-week off-cycle exists to let receptor sensitivity recover. Canine evidence is Level V — mechanistic and extrapolated, not clinical.

References

  1. 1.Goldspink G Mechanical signals, IGF-I gene splicing, and muscle adaptation. Physiology, 2005. PMID 16174871

Educational information — not veterinary medical advice

Everything on this page is compiled from published peer-reviewed literature for educational and research purposes. It does not establish a veterinarian-client-patient relationship (VCPR) and is not a substitute for veterinary examination and diagnosis. Most compounds described here are investigational or used off-label and are not FDA-approved for these purposes in dogs. Extralabel drug use in animals requires a valid VCPR and the direct supervision of a licensed veterinarian under AMDUCA (21 U.S.C. §360b). Dosing figures are reported as they appear in the source literature and are not recommendations.